Development and validation of a four-gene prognostic signature derived from disulfidptosis- and cuproptosis-related genes in oral squamous cell carcinoma
Yao Yao, Xiaoshan Li, Ziyan Pang, Wenming Kang, Liqiang Gong, Qi Zhou, Chen Mao · 2026
Read Development and validation of a four-gene prognostic signature derived from disulfidptosis- and cuproptosis-related genes in oral squamous cell carcinoma by Yao Yao, Xiaoshan Li, Ziyan Pang, Wenming Kang, Liqiang Gong, Qi Zhou, Chen Mao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13526731.txt.
Description
Yao Yao and colleagues build, in a 2026 study, a four-gene prognostic signature for oral squamous cell carcinoma drawn from two newly described cell-death pathways, disulfidptosis and cuproptosis. Genes from these pathways might carry outcome information, yet no validated combined signature existed for this mouth cancer. Public expression cohorts supplied discovery, training, and validation data.
The signature combines CDKN2A, FLNA, GLS, and TLN1, and its risk score predicted survival independently of six clinical factors. A combined clinical-genomic model beat either part alone, reaching a five-year accuracy measure of 0.805 in area terms. The signature validated significantly in two external cohorts, with a matching trend in a third. Single-cell data placed one gene mainly in malignant cells and two in fibroblasts, hinting at tumor-stroma crosstalk, and laboratory assays confirmed all four genes were raised in cancer cell lines.
Catalog record
| CREATOR | Yao Yao, Xiaoshan Li, Ziyan Pang, Wenming Kang, Liqiang Gong, Qi Zhou, Chen Mao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53539 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |